Equity Capital Markets

Soleno Therapeutics, Inc.

04/24
|
$138.0 Million
Soleno Therapeutics, Inc.
Piper Sandler served as bookrunner for Soleno Therapeutics, Inc. on its CMFO
Sub-Type
CMFO
Sector
Healthcare
Sub-Sector
Biopharma

Related Transactions

All Transactions
$202.0 Million
kestra
Kestra Medical Technologies
Initial Public Offering
Active Bookrunner
$52.5 Million
Tenaya
Tenaya Therapeutics
Confidentially Marketed Follow-On Offering
Active Bookrunner
$300.0 Million
community healthcare
Community Healthcare Trust
ATM
Sole Placement Agent
$50.0 Million
rithm
Rithm Property Trust
Preferred Stock
Left Bookrunner
$150.0 Million
altimmune
Altimmune, Inc
ATM
Lead Placement Agent
Sailpoint
SailPoint Technologies Inc.
Initial Public Offering
Passive Bookrunner
Northpointe
Northpointe Bancshares, Inc.
Initial Public Offering
Co-Manager
$1.5 Billion
charles schwab
The Charles Schwab Corporation
Repurchase of Common Stock
Financial Advisor
$105.0 Million
aligos
Aligos Therapeutics
PIPE
Joint Placement Agent
$185.0 Million
tectonic
Tectonic Therapeutics
PIPE
Joint Placement Agent
$1.3 Billion
Viper Energy Partners LP
Viper Energy Partners
Confidentially Marketed Follow-On Offering
Co-Manager
$264.5 Million
atlas
Atlas Energy Solutions Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$221.0 Million
Beta Bionics
Beta Bionics, Inc.
Initial Public Offering
Active Bookrunner
$491.3 Million
Flowco
Flowco
Initial Public Offering
Active Bookrunner
$50.0 Million
Personalis, Inc
Personalis, Inc
ATM
Sole Placement Agent
$40.0 Million
Monopar Therapeutics
Monopar Therapeutics
Underwritten Registered Direct and PIPE
Active Bookrunner

© 2025 Piper Sandler Companies. Since 1895. All rights reserved.